On May 7, 2024, Shah Capital Management, Inc. urged Novavax, Inc. shareholders to vote against the re-election of 3 directors and opposed proposals related to executive compensation, weeks after pushing for a board shakeup at the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.66 USD | -1.33% | -9.57% | +163.75% |
06-28 | Novavax: ACIP in favor of Covid 24/25 vaccine | CF |
06-27 | US CDC advisers recommend updated COVID vaccines for those six months and older | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.75% | 1.78B | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.71% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Shah Capital Management Urges Shareholders to Vote Against Novavax?s Directors